All One Health Content – Page 51
-
NewsFungi recognise shapes and adjust direction of growth
A study suggests that the mycelial network of fungi can communicate information about its surroundings throughout the entire network, and change its direction of growth accordingly based on the shape.
-
NewsViral messaging can deliver lessons on how infectious diseases spread
A new study explores a hybrid approach to understanding social networks that involves inferring not just social contacts but also the rules that govern how contagion and information spread.
-
NewsScientists uncover Chlamydia’s sneak attack strategies
Researchers have described the structural and functional methods Chlamydia pneumoniae uses to penetrate the human cell: It mimics molecular structures of the human cell (so-called “molecular mimicry”) and uses them for its attack.
-
NewsBioengineer awarded $3.4M for project to end polio
Bioengineer Kevin McHugh has been awarded $3.4 million for a project to incorporate protection against poliomyelitis into the combination vaccine that protects against five common and dangerous childhood diseases.
-
NewsZika virus offeres potential as treatment for brain cancer: review
Fourteen studies showed that Zika virus reduced cell viability, inhibited the growth and proliferation of glioma stem cells (GSCs), and decreased Bcl2 expression in central nervous system tumors, potentially enhancing chemotherapy and radiotherapy effects.
-
NewsGut microbiome has central role in human aging
The gut microbiome holds a central role in human aging, influencing everything from metabolic function to immune health, a new review shows.
-
NewsHospitals that are understaffed for infection prevention and control have higher rates of infection, study says
Inadequate infection prevention and control staffing levels are associated with higher rates of healthcare-associated infections, according to a new study published today in the American Journal of Infection Control. The study, conducted by the APIC Center for Research, Practice & Innovation, summarizes a pilot project to evaluate ...
-
NewsApplied Microbiology International’s 2023 Honorary Fellowship goes to Dr Chikwe Ihekweazu
Applied Microbiology International (AMI) is delighted to announce its 2024 Honorary Fellowship goes to Dr Chikwe Ihekweazu, who serves as Deputy Executive Director of the World Health Organization (WHO) Health Emergencies Programme.
-
NewsHibernating ribosomes flip upside down in starving yeast cells
Scientists have discovered a curious way in which cells adapt to starvation – a mechanism with potential cancer implications.
-
NewsIn a warming world, public needs to know more about protections from mosquito-borne illnesses
Very few (15%) among the American public worry that they or their families will contract dengue or West Nile virus over the new three months, according to the latest Annenberg Public Policy Center (APPC) health knowledge survey.
-
NewsScientists discover series of SARS-CoV-2 mpro inhibitors for potential COVID-19 treatments
New research has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 treatments that, according to preclinical testing, effectively inhibits COVID-19 and synergizes with existing anti-COVID therapies.
-
NewsStudy reveals how parasites thrive by balancing specialisation with exploiting diverse species communities
A new study reveals that the prevalence of malaria-like blood parasites in birds increases with the number of species present in local bird communities. The findings indicate that parasites thrive when they can exploit a wide range of different bird species.
-
NewsTrials show common cold medication significantly improved symptoms in less than two days
Applied Biological Laboratories will present results of a clinical trial which showed Biovanta significantly improved common cold symptoms including sore throat, cough, runny nose, congestion, chills, and sneezing in less than two days.
-
NewsScientists engineer new enzyme to produce synthetic genetic material
Researchers have engineered an efficient new enzyme that can produce a synthetic genetic material called threose nucleic acid. The ability to synthesize artificial chains of TNA advances the discovery of therapeutic options to treat cancer and other diseases.
-
NewsStudy finds persistent infection could explain long COVID in some people
Researchers found people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood, compared to those without long COVID symptoms.
-
NewsScientists develop enzyme complex to find Achilles heel of protozoan parasite
In an effort to find a new weak spot of the protozoan parasite Trichomonas vaginalis, researchers have succeeded in preparing a key enzyme complex – the proteasome.
-
NewsFarewell to John Rigarlsford: a giant in biocides
Former AMI president Dr Peter Silley pays tribute to longstanding member and former committee representative John Rigarlsford, who recently passed away following a short illness.
-
NewsPolicy change may be helping to drive rise in treatment-resistant vaginal thrush
A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid significant yearly increases in the prevalence of fungal infections caused by fungal Candida species, suggests the first study of its kind.
-
NewsGut hormones could hold the key to fighting fatty liver disease
A new study reveals the crucial role of intestinal absorption in preventing dietary-induced fatty liver disease.
-
NewsRates of a tick-borne parasitic disease are on the rise
Cases of babesiosis increased 9% per year, on average, between 2015 and 2022 and nearly half were co-infected with another tick-borne illness such as Lyme disease, according to a new study.